🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neuropsychological Patterns of Suicide Ideators and Suicide Attempters

Recruitingn/aAges 18 Years - anyAllUniversity of Bern
NCT06248268 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment. The overall aim of project 1 is to determine (neuro-) psychological differences between suicide attempters, suicide ideators, a clinical control group, and healthy controls. Study participants in project 1 will participate in a one-time (neuro-) psychological assessment. Project 1 of this study is an observational cross-sectional study with four groups that will be conducted at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland): Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort, without neither suicidal behavior or ideation (CLIN) and the healthy group (HL

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years Additional inclusion criterion for the SUAT group in project 1: • At least one previous suicide attempt Additional inclusion criterion for the SUID group in project 1: • Suicidal ideation Additional inclusion criterion for the CLIN group in project 1: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis For the HLTH group, no further inclusion criteria are formulated. Exclusion Criteria: The presence of any one of the following exclusion criteria leads to exclusion of the subject: * Serious cognitive impairment * Any current psychotic disorder * Any current medication, which substantially impairs the attention span, reaction rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study) Additional exclusion criterion for the SUID group: • Previous suicidal behavior Additional exclusion criteria for the CLIN and HLTH groups: * Previous suicidal behavior * Suicidal ideation Additional exclusion criterion for the HLTH group: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis
💊

What it tests

  • (Neuro-)psychological assessment
📍

Where

1 site
University Hospital of Psychiatry and Psychotherapy, University of Bern
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy